14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CRNC vs IMMR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Immersion Corp (IMMR) captures the overall head-to-head institutional edge over Cerence Inc. (CRNC) on higher Unified Composite conviction (44.1/100 HOLD vs. 43.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while CRNC wins 5–1 across the 6-pillar growth and valuation breakdown. CRNC trades at $6.13 (44.2x Forward P/E, 11.9% operating margin) versus IMMR at $6.54 (26.7x Forward P/E, 1.3% operating margin).
Growth vs. Quality Trade-Off: IMMR earns the overall head-to-head edge with a stronger Unified Composite Score (44.1/100 HOLD vs. CRNC 43.5/100 HOLD) and 1.17β · 29% Vol risk profile, whereas CRNC leads top-line expansion (+11.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CRNC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile IMMR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Software - Application value chain with $222.8M market capitalization and 1.3% operating margin.
OpEx & R&D Reinvestment20.2% of Rev ($350M)
90D Engineering Disclosures0 Published
Investor FAQ CRNC vs IMMR Key Questions & Quantitative Answers
As of Nov 20, 2026, Immersion Corp (IMMR) captures the overall head-to-head institutional edge over Cerence Inc. (CRNC) on higher Unified Composite conviction (44.1/100 HOLD vs. 43.5/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples), while CRNC wins 5–1 across the 6-pillar growth and valuation breakdown. CRNC trades at $6.13 (44.2x Forward P/E, 11.9% operating margin) versus IMMR at $6.54 (26.7x Forward P/E, 1.3% operating margin). Growth vs. Quality Trade-Off: IMMR earns the overall head-to-head edge with a stronger Unified Composite Score (44.1/100 HOLD vs. CRNC 43.5/100 HOLD) and 1.17β · 29% Vol risk profile, whereas CRNC leads top-line expansion (+11.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CRNC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile IMMR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CRNC leads the Growth & Scale pillar: CRNC posts +11.8% YoY revenue growth and -92.0% YoY earnings growth on $309M TTM revenue (78.7% gross margin, 11.9% operating margin), compared with IMMR at +0.8% YoY revenue growth and -61.5% YoY earnings growth on $1.73B TTM revenue (21.5% gross margin, 1.3% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CRNC cumulative revenue shifted -16.7% while IMMR shifted +4225.0%. In operating R&D and SG&A reinvestment, CRNC deploys 66.8% of Rev ($207M) (0 90-day corporate R&D disclosures) versus 20.2% of Rev ($350M) (0 disclosures) for IMMR.
IMMR screens cheaper on headline valuation multiples. CRNC trades at 44.2x Forward P/E, 44.2x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (25.4% FCF margin), whereas IMMR trades at 26.7x Forward P/E, 19.7x Trailing P/E, 2.21x PEG, and 0.2x EV/Revenue (3.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRNC (-9.6% ROE) versus IMMR (3.3% ROE) capital efficiency.
In options market volatility and institutional positioning, CRNC carries 249.8% implied volatility (100th %ile, Extreme (>80th %ile)), a 9.43x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.74β · 66% Vol realized risk). By comparison, IMMR carries 59.5% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.17β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.